Anterior and Posterior Approaches of Suprascapular Nerve Block

March 3, 2024 updated by: Ebru Girgin Dinç, MD, Istanbul Medeniyet University

Comparison of Anterior and Posterior Approaches of Suprascapular Nerve Block in Arthroscopic Shoulder Surgery

Suprascapular nerve is a mixed motor and sensory peripheral nerve arising from the superior trunk of brachial plexus.The suprascapular nerve runs through the posterior triangle of the neck, anterior of the trapezius muscle and dorsal of the omohyoid muscle, in direction of the scapula. Suprascapular nerve block is performed by anterior and posterior approach. Posterior approach of the suprascapular nerve block has been shown for many years to provide effective analgesia in the shoulder region for the chronic and acute pain. There are studies showing that suprascapular block with anterior approach provides effective analgesia in shoulder arthroscopy.

The aim of our study was to compare anterior and posterior approaches of suprascapular nerve block in terms of analgesic efficacy and patient safety.

Study Overview

Detailed Description

This study is a prospective randomized clinical trial will be conducted between March 2022 and March 2023.Participant will divide into two groups as participant who underwent suprascapular nerve block with the anterior approach and participant who underwent suprascapular nerve block with the posterior approach. Bupivacaine 5 ml %0.5 will be injected both group. Diaphragmatic thickness fraction will be evaluated with ultrasound left and right 7.-8. subcostal anterior axillary border with the participant with the semi-sitting position. Diaphragmatic thickness fraction will measure before the block and after 30 minutes the surgery. Participants will administered intravenous morphine patient controlled analgesia for 24 hours stay. The amount of opioid analgesics given in both groups will be determined (in mg). Postoperative 4th, 6th, 12th, 24th hour Visual Analogue Scale scores of the participants and opioid consumptions until that hours will be evaluated. An addition participant will be determined according to the surgery.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34722
        • İstanbul medeniyet University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient who accepts to study protocol
  • Scheduled for shoulder surgery
  • Between the ages of 18 and 80

Exclusion Criteria:

  • Patients with coagulopathy
  • Patients with a history of local anesthetic drug allergy and toxicity
  • Patients with advanced organ failure
  • Patients with mental retardation
  • Patients with infection present at the injection site
  • Patients with diaphragm paralysis
  • Pregnant patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Posterior suprascapular block
Suprascapular block performed by posterior approach
Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by posterior approach
Active Comparator: Anterior suprascapular block
Suprascapular block performed by anterior approach
Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by anterior approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain at the first postoperatively 30th. Min.
Time Frame: The first postoperative 30 minutes
Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.
The first postoperative 30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diaphragmatic movements
Time Frame: Baseline (Before the block performed) and 30 minutes after the end of surgery
Ratio of diaphragm thickness in end-inspiration and end-expiration measured by ultrasonography
Baseline (Before the block performed) and 30 minutes after the end of surgery
Postoperative opioid analgesic consumption (morphine)
Time Frame: postoperative 4 hours
milligram
postoperative 4 hours
Postoperative opioid analgesic consumption (morphine)
Time Frame: postoperative 6 hours
milligram
postoperative 6 hours
Postoperative opioid analgesic consumption (morphine)
Time Frame: postoperative 12 hours
milligram
postoperative 12 hours
Postoperative opioid analgesic consumption (morphine)
Time Frame: postoperative 24 hours
milligram
postoperative 24 hours
Peroperatively opioid analgesic consumption (Remifentanil)
Time Frame: postoperative 0th.min
milligram
postoperative 0th.min
Postoperative opioid analgesic consumption (morphine)
Time Frame: postoperative 30th. Min
milligram
postoperative 30th. Min
Postoperative pain at postoperative 4th. Hours
Time Frame: at postoperative 4th. Hours
Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.
at postoperative 4th. Hours
Postoperative pain at postoperative 6th. Hours
Time Frame: at postoperative 6th. Hours
Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.
at postoperative 6th. Hours
Postoperative pain at postoperative 12th. Hours
Time Frame: at postoperative 12th. Hours
Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.
at postoperative 12th. Hours
Postoperative pain at postoperative 24th. Hours
Time Frame: at postoperative 24th. Hours
Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.
at postoperative 24th. Hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ebru Girgin Dinç, MD, İstanbul medeniyet University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2022

Primary Completion (Actual)

March 15, 2023

Study Completion (Actual)

March 15, 2023

Study Registration Dates

First Submitted

April 18, 2022

First Submitted That Met QC Criteria

July 1, 2022

First Posted (Actual)

July 5, 2022

Study Record Updates

Last Update Posted (Estimated)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 3, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

After the article is accepted by the journal

IPD Sharing Time Frame

After the article is accepted by the journal

IPD Sharing Access Criteria

After the article is accepted by the journal

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Posterior suprascapular block

3
Subscribe